This resource collection includes a structured EV-ICD appeal template and a fully written sample appeal letter to support clinicians in securing coverage approval. Together, these tools provide a step-by-step framework for establishing standard ICD eligibility, clearly defining clinical mismatch with conventional systems, framing EV-ICD as a risk-reduction strategy, and effectively addressing “experimental/investigational” denial language.
Designed for practical use, the toolkit helps standardize documentation, strengthen medical necessity arguments, and improve the clarity and consistency of EV-ICD coverage submissions.
A joint statement from the Heart Rhythm Society (HRS) and the American College of Cardiology (ACC), advocating for payer coverage of the extravascular implantable cardioverter-defibrillator (EV-ICD), summarizes the clinical evidence supporting the safety, effectiveness, and patient-centered benefits of the EV-ICD and calls for coverage policies that enable physicians to select the most appropriate ICD technology for individual patients.
Submit Feedback
- Tools